Tweet
EU plans risk reduction steps for Servier, Amgen heart drug Yahoo News LONDON (Reuters) - Experts at the European Medicines Agency have recommended measures to reduce the risks associated with a drug from private French company Servier that helps lower the heart rate and which was licensed to U.S. group Amgen last ... and more » |
More...